IFF Invests in High-Moisture Extrusion Technology from Coperion

IFF has recently installed three HME systems in IFF's innovation hubs across Europe, the United States and Singapore.
IFF has recently installed three HME systems in IFF's innovation hubs across Europe, the United States and Singapore.
courtesy of IFF

IFF has announced the investment in high-moisture extrusion (HME) technology from Coperion, a global industrial and technological company that specializes in extrusion technology.

Related: IFF, Unilever and Wageningen University Partner to Address Plant-based Flavor Challenges

This investment is said to further enhance the possibilities for meat alternatives by enabling the company to support manufacturers in replicating the appearance and fibrous texture of conventional whole-muscle meat.

IFF has recently installed three HME systems in IFF's innovation hubs across Europe, the United States and Singapore. These systems are said to be operational and feature highly precise powder and liquid feeders to ensure both high-quality production and remarkable flexibility. IFF is integrating HME into its IFF Product Design1 approach, combining ingredient and flavor design expertise with advanced industry insights to provide end-to-end Product Design solution

“Through the synergistic integration of HME technology and IFF's Re-Imagine Protein2 Innovation program, the goal is to pioneer new and innovative meat alternative products that offer a level of consumer acceptance not yet achieved in the market,” said Alexander Lamm, principal food designer, Nourish, IFF. “Consumer demand for plant-based products that offer an experience akin to eating meat is huge, and HME is one of the best ways to meet it. This investment will allow us to deliver a wide range of benefits to our customers, helping them create innovative new meat analogs, and supporting them all the way from ideation to commercialization, ultimately allowing our customers to develop successful products faster.”

“HME is a newer and changing technology which offers a huge range of possibilities for the future. Especially as concerns about feeding a fast-growing global population in a healthy and sustainable way mount,” said John Sheehy, global key account manager, Alternative Proteins, Coperion. “We’re delighted to collaborate with a global leader like IFF, and to help it integrate HME testing into its capabilities. Coperion is honored and excited to have this opportunity to share our knowledge and expertise to help IFF develop the next generation of fibrous plant-based proteins.”

1IFF PRODUCT DESIGN is a trademark of IFF

2RE-IMAGINE PROTEIN is a registered trademark of IFF

More in Regulatory & Research